{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:46:35Z","timestamp":1782459995627,"version":"3.54.5"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Drug reactions affecting the vulva are understudied and underreported, with some having the potential to cause serious morbidity through long-term sequelae. We conducted a literature review to investigate the current evidence about vulval drug eruptions. We aimed to establish the extent of drug reactions affecting the vulva, identify the common culprit drugs, and review current evidence and guidelines regarding their management. The vulval involvement seen in Steven\u2013Johnson syndrome, toxic epidermal necrolysis and fixed drug eruption forms the focus of this review, but we also summarize the current evidence regarding less common reactions.<\/jats:p>","DOI":"10.1093\/ced\/llad369","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T11:52:45Z","timestamp":1699012365000},"page":"211-217","source":"Crossref","is-referenced-by-count":3,"title":["Drug eruptions and the vulva"],"prefix":"10.1093","volume":"49","author":[{"given":"Hannah M","family":"Binns","sequence":"first","affiliation":[{"name":"Wexham Park Hospital, Frimley NHS Trust , Slough , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Tasker","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M","family":"Lewis","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2024021702380854200_llad369-B1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2024021702380854200_llad369-B3","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"2024021702380854200_llad369-B4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/ijd.15676","article-title":"Vulvovaginal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: management and techniques used to reduce gynecologic sequelae","volume":"61","author":"Crowder","year":"2022","journal-title":"Int J Dermatol"},{"key":"2024021702380854200_llad369-B6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijwd.2021.08.012","article-title":"Vulvovaginal and ocular involvement and treatment in female patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a review","volume":"7","author":"Magone","year":"2021","journal-title":"Int J Womens Dermatol"},{"key":"2024021702380854200_llad369-B7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0029-7844(97)00596-6","article-title":"Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases","volume":"91","author":"Meneux","year":"1998","journal-title":"Obstet Gynecol"},{"key":"2024021702380854200_llad369-B8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jaad.2019.08.031","article-title":"Vulvovaginal manifestations in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevention and treatment","volume":"85","author":"O\u2019Brien","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2024021702380854200_llad369-B9","doi-asserted-by":"crossref","first-page":"e00404","DOI":"10.1016\/j.crwh.2022.e00404","article-title":"Stevens-Johnson syndrome with vulvar involvement: a case report and literature review","volume":"34","author":"Hollingsworth","year":"2022","journal-title":"Case Rep Womens Health"},{"key":"2024021702380854200_llad369-B10","first-page":"81","article-title":"Prevention of vulvovaginal sequelae in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"4","author":"Kaser","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"2024021702380854200_llad369-B11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijwd.2020.04.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: a systematic review","volume":"6","author":"Sharma","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"2024021702380854200_llad369-B12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-023-02631-7","article-title":"Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus","volume":"18","author":"Ingen-Housz-Oro","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"2024021702380854200_llad369-B13","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319894469","article-title":"Multidisciplinary care in Stevens-Johnson syndrome","volume":"11","author":"Shanbhag","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"2024021702380854200_llad369-B14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.burns.2015.12.001","article-title":"Burn unit care of Stevens Johnson syndrome\/toxic epidermal necrolysis: a survey","volume":"42","author":"Le","year":"2015","journal-title":"Burns"},{"key":"2024021702380854200_llad369-B15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjd.17841","article-title":"British Association of Dermatologists\u2019 guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in children and young people, 2018","volume":"181","author":"Mcpherson","year":"2019","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B16","first-page":"308","article-title":"[Fixed erythemato-pigmented rash due to antipyrine]","volume":"5","author":"Brocq","year":"1894","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"key":"2024021702380854200_llad369-B17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-4362.1998.00451.x","article-title":"Drugs causing fixed eruptions: a study of 450 cases","volume":"37","author":"Mahboob","year":"1998","journal-title":"Int J Dermatol"},{"key":"2024021702380854200_llad369-B18","first-page":"81","article-title":"Vulvar fixed drug eruption: a report of 13 cases","volume":"52","author":"Fischer","year":"2007","journal-title":"J Reprod Med"},{"key":"2024021702380854200_llad369-B19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1440-0960.2009.00519.x","article-title":"Vulval fixed drug eruption due to paracetamol","volume":"50","author":"Drummond","year":"2009","journal-title":"Aust J Dermatol"},{"key":"2024021702380854200_llad369-B20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1610-0387.2007.06491.x","article-title":"Fixed drug eruption: state of the art","volume":"6","author":"Ozkaya","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"2024021702380854200_llad369-B21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1525-1470.2002.00078.x","article-title":"Fixed drug eruption in the genital area in 15 boys","volume":"19","author":"Nussinovitch","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"2024021702380854200_llad369-B22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0190-9622(03)01588-3","article-title":"Specific site involvement in fixed drug eruption","volume":"49","author":"\u00d6zkaya-Bayazit","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2024021702380854200_llad369-B23","first-page":"56","article-title":"Genital fixed drug eruptions","volume":"62","author":"Sehgal","year":"1986","journal-title":"Genitourin Med"},{"key":"2024021702380854200_llad369-B24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.1987.tb05819.x","article-title":"Trimethoprim associated fixed drug eruption","volume":"116","author":"Hughes","year":"1987","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2230.2008.02840.x","article-title":"Fixed drug eruption of the vulva secondary to fluconazole","volume":"33","author":"Wain","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"2024021702380854200_llad369-B26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajog.2021.09.042","article-title":"Vulvar and\u00a0areolar fixed drug eruption","volume":"226","author":"Abril-P\u00e9rez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2024021702380854200_llad369-B27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(87)70220-5","article-title":"Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline","volume":"17","author":"Shelley","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"2024021702380854200_llad369-B28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0015-0282(16)60149-8","article-title":"Fixed cutaneous eruptions to seminal-plasma challenge: a case report","volume":"50","author":"Best","year":"1988","journal-title":"Fertil Steril"},{"key":"2024021702380854200_llad369-B29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) \u2013\u200c a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"2024021702380854200_llad369-B30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13256-020-02504-8","article-title":"Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report","volume":"14","author":"Coleman","year":"2020","journal-title":"J Med Case Rep"},{"key":"2024021702380854200_llad369-B31","first-page":"8","article-title":"Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: case presentation and literature review","volume":"16","author":"Copaescu","year":"2020","journal-title":"Allergy"},{"key":"2024021702380854200_llad369-B32","first-page":"507","article-title":"Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine","volume":"49","author":"Goh","year":"2008","journal-title":"Singapore Med J"},{"key":"2024021702380854200_llad369-B33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.35248\/2684-124X.18.3.144","article-title":"Ciprofloxacin-induced acute generalized exanthematous pustulosis","volume":"3","author":"Sheth","year":"2018","journal-title":"Dermatol Case Rep"},{"key":"2024021702380854200_llad369-B34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2133.1980.tb06574.x","article-title":"Drug-induced anogenital cicatricial pemphigoid","volume":"102","author":"van Joost","year":"1980","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B35","first-page":"565","article-title":"Bevacizumab associated mucous membrane pemphigoid","volume":"16","author":"Ormond","year":"2010","journal-title":"Oral Dis"},{"key":"2024021702380854200_llad369-B36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2230.1985.tb00589.x","article-title":"Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis \u2013 a report of three cases","volume":"10","author":"Shuttleworth","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"2024021702380854200_llad369-B37","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology \u2013 Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024021702380854200_llad369-B38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1192\/bjp.176.3.299-a","article-title":"Fluoxetine-induced anaesthesia of vagina and nipples","volume":"176","author":"Michael","year":"2000","journal-title":"Br J Psychiatry"},{"key":"2024021702380854200_llad369-B39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2002-33196","article-title":"Paroxetine-induced vaginal anaesthesia","volume":"35","author":"Michael","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"2024021702380854200_llad369-B40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0022-5347(17)36450-9","article-title":"Priapism of the clitoris: a case report following trazodone use","volume":"149","author":"Pescatori","year":"1993","journal-title":"J Urol"},{"key":"2024021702380854200_llad369-B41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004850-199907000-00009","article-title":"Nefazodone-induced clitoral priapism","volume":"14","author":"Brodie-Meijer","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"2024021702380854200_llad369-B42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004850-199703000-00008","article-title":"Citalopram-associated clitoral priapism: a case series","volume":"12","author":"Berk","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"2024021702380854200_llad369-B43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.jcp.0000138779.78633.0c","article-title":"Olanzipine induced clitoral priapism","volume":"24","author":"Burcur","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"2024021702380854200_llad369-B44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ijd.16449","article-title":"Gliflozin (SGLT2 inhibitor) induced vulvitis","volume":"62","author":"Mounsey","year":"2023","journal-title":"Int J Dermatol"},{"key":"2024021702380854200_llad369-B45","first-page":"65","article-title":"Vaginal ulcerations due to lithium carbonate therapy","volume":"48","author":"Srebrnik","year":"1991","journal-title":"Cutis"},{"key":"2024021702380854200_llad369-B46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0895-4356(94)00239-M","article-title":"Berg LTWDJ Van Den","volume":"48","author":"Sturkenboom","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"2024021702380854200_llad369-B47","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.lanepe.2021.100266","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: a real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2024021702380854200_llad369-B48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2230.2012.04357.x","article-title":"Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus","volume":"37","author":"Worsnop","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"2024021702380854200_llad369-B49","doi-asserted-by":"crossref","first-page":"e16895","DOI":"10.1097\/MD.0000000000016895","article-title":"Low-dose methotrexate-induced vulvar edema","volume":"98","author":"Jia","year":"2019","journal-title":"Medicine"},{"key":"2024021702380854200_llad369-B50","doi-asserted-by":"crossref","first-page":"h5421","DOI":"10.1136\/bmj.h5421","article-title":"A persistent vulval ulcer","volume":"351","author":"Maybury","year":"2015","journal-title":"BMJ"},{"key":"2024021702380854200_llad369-B51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2133.2006.07363.x","article-title":"Cutaneous, perivulvar and perianal ulcerations induced by nicorandil","volume":"155","author":"Claeys","year":"2006","journal-title":"Br J Dermatol"},{"key":"2024021702380854200_llad369-B52","first-page":"182","article-title":"Vulval ulceration associated with foscarnet","volume":"68","author":"Lacey","year":"1992","journal-title":"Genitourin Med"},{"key":"2024021702380854200_llad369-B53","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0190-9622(09)80281-8","article-title":"Foscarnet-induced vulvar erosion","volume":"28","author":"Caumes","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2024021702380854200_llad369-B54","first-page":"14","article-title":"Superficial ulceration on the vulva","volume":"99","author":"Manam","year":"2017","journal-title":"Cutis"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad369\/54928128\/llad369.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/3\/211\/56679010\/llad369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/3\/211\/56679010\/llad369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:38:44Z","timestamp":1708137524000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/3\/211\/7334280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,10,31]]},"published-print":{"date-parts":[[2024,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad369","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,10,31]]}}}